GlobalData on MSN12d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini BThe latest authorised panel targets bacterial infections, including Campylobacter, Shigella, Yersinia enterocolitica, and ...
A cluster of 20 genetically linked Shigella sonnei sequence type (ST) 152 cases were first reported by the United Kingdom. Austria, France, Ireland, and the Netherlands have also recorded ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results